Advanced Aseptic Liquid Processing Technology
Weiler Engineering, Inc.’s corporate focus is to provide advanced aseptic liquid processing technology through the application of customized ASEP-TECH® Blow/Fill/Seal machinery and services. Serving the pharmaceutical industry has been Weiler’s core business for more than 50 years. Weiler focuses on the patient and strives to provide the safest sterile aseptic packaging process for pharmaceutical liquids. This concept is based on studying and implementing learned technological advances driven by Science.
Weiler Engineering, Inc.’s corporate focus is to provide advanced aseptic liquid processing technology through the application of customized ASEP-TECH® Blow/Fill/Seal machinery and services. Serving the pharmaceutical industry has been Weiler’s core business for more than 50 years. Weiler focuses on the patient and strives to provide the safest sterile aseptic packaging process for pharmaceutical liquids. This concept is based on studying and implementing learned technological advances driven by Science.
Weiler Engineering, Inc.’s, ASEP-TECH® Blow/Fill/Seal machines are manufactured in Elgin, IL USA with 85% of production exported to more than 35 companies around the world.
Handling Sterile Potent, Powders Inside a Single Use, Disposable Aseptic Isolator with Martyn Ryder
April 28th 2021During this podcast we shall be discussing how sterile potent powders are becoming more common in the bio-pharmaceutical industry and the challenges around handling these powders in conventional aseptic containment systems. Review the overarching benefits of compliant. single use isolator systems when handling sterile products and how they mitigate the risk associated with potent product batch manufacture.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
